Cost-effectiveness analysis of molecular diagnosis by next-generation sequencing versus sequential single testing in metastatic non-small cell lung cancer patients from a south Spanish hospital perspective

Enrique de Alava,Maria Jesus Pareja,David Carcedo,Natalia Arrabal,Jose-Francisco Garcia,Reyes Bernabe-Caro

Expert review of pharmacoeconomics & outcomes research（2022）

Cited 4|Views14
No score
Key words
Non-small cell lung cancer (NSCLC),molecular profiling,oncogenic drivers,cost-effectiveness,next-generation sequencing,sequential single testing
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined